Shruthi Dawalji
About Shruthi Dawalji
Shruthi Dawalji is an Associate Research Analyst at Thomson Reuters, specializing in interpreting personal genome data for precision and preventative therapies. She has over a decade of experience in competitive intelligence research within the pharmaceutical industry.
Work at Thomson Reuters
Shruthi Dawalji has been employed at Thomson Reuters as an Associate Research Analyst since 2012. Over the past 12 years, she has worked in Toronto, Ontario, Canada, focusing on competitive intelligence research. Her role involves providing clients with insights into the pharmaceutical industry, which aids in strategic decision-making. Additionally, she mentors team analysts by conducting regular quality audits to maintain high standards of work.
Education and Expertise
Shruthi Dawalji has a solid educational background in the sciences. She studied at Guntur Vikas Junior College from 2003 to 2005, focusing on Zoology, Physics, Chemistry, and Botany. She then pursued a degree in Pharmacy at Sree Dattha Institute of Pharmacy from 2006 to 2010, followed by further studies at St. Peter’s Institute of Pharmaceutical Sciences from 2010 to 2012. Her expertise includes interpreting personal genome data for precision and preventative therapies and curating trial data related to genetic, metabolomic, proteomic, transcriptomic, or epigenetic information.
Background
Shruthi Dawalji's academic journey began at Guntur Vikas Junior College, where she studied various scientific disciplines. She transitioned into the field of Pharmacy, completing her studies at two different institutions. This educational foundation has equipped her with the necessary skills to excel in her current role as an Associate Research Analyst, where she applies her knowledge to the pharmaceutical sector.
Achievements
Throughout her career at Thomson Reuters, Shruthi Dawalji has contributed to the field of competitive intelligence research within the pharmaceutical industry. She has played a significant role in mentoring team analysts, ensuring the quality of research outputs through regular audits. Her specialization in interpreting personal genome data and curating complex trial data showcases her commitment to advancing knowledge in precision and preventative therapies.